What does a positive hemoglobin solubility test indicate and how should it be managed?

Positive Hemoglobin Solubility Test

A positive hemoglobin solubility test indicates the presence of hemoglobin S (HbS) and requires immediate confirmatory testing with hemoglobin electrophoresis or HPLC to distinguish between sickle cell trait (heterozygous) and sickle cell disease (homozygous), as the solubility test cannot differentiate between these conditions.

What the Test Detects

The hemoglobin solubility test (also called sickle cell solubility test or SCST) detects the presence of HbS based on its reduced solubility in specific buffer solutions 1. When positive, it confirms HbS is present but provides no information about:

• The quantity of HbS
• Whether the patient has sickle cell trait (AS) versus sickle cell disease (SS)
• The presence of other hemoglobin variants (SC, S-beta thalassemia)

The test demonstrates excellent sensitivity and specificity (approaching 100%) when performed correctly, and can detect HbS levels as low as 12.1% 2 or even >5% with modified techniques 3.

Critical Management Steps

Immediate Actions

1. Order confirmatory testing: Hemoglobin electrophoresis or HPLC is mandatory 1, 4. Never rely on solubility testing alone for diagnosis.

2. Assess clinical context:

   • Check hemoglobin level and hematocrit
   • Review patient's ethnicity and family history
   • Document any symptoms of anemia or hemolytic crisis

Interpretation of Confirmatory Results

After HPLC/electrophoresis:

• Sickle cell trait (HbAS): Typically 35-45% HbS, remainder HbA. Generally asymptomatic, requires genetic counseling but no treatment.

• Sickle cell disease (HbSS): >80% HbS, no HbA present. Requires comprehensive disease management including hydroxyurea consideration, prophylactic penicillin (in children), folic acid supplementation, and regular monitoring.

• Compound heterozygotes (HbSC, HbS-beta thalassemia): Variable HbS percentages with other variants. Clinical severity varies; manage based on specific genotype.

Important Caveats and Pitfalls

False Positives

The solubility test can yield false positive results in several situations 5, 6:

• Rare hemoglobin variants: Hemoglobin Geldrop St. Anna and other variants can cause false positives 6
• Polycythemia: Elevated hematocrit may interfere with test interpretation 4
• Technical errors: Improper sample handling or reagent preparation

In one study from Haiti, 5 of 19 positive solubility tests (26%) were false positives when confirmed by genotyping 5.

False Negatives

While rare with properly performed tests, false negatives can occur with:

• Severe anemia (hemoglobin <7 g/dL)
• Recent blood transfusion
• Very low HbS percentages in some trait carriers

Interference with Other Tests

Critical consideration for diabetes management: In patients with sickle cell disease or trait, HbA1c testing may be unreliable for diabetes diagnosis and monitoring 7, 8. The 2019 ADA guidelines explicitly state that in conditions with altered hemoglobin (including sickle cell disease), only plasma glucose criteria should be used to diagnose diabetes 7. Use fasting plasma glucose or oral glucose tolerance testing instead.

Special Populations

Blood Donors

Solubility testing is commonly used to screen blood products for patients with sickle cell disease who require HbS-negative blood 6. All positive screens must be confirmed before deferring donors.

Pregnant Women

If sickle cell trait or disease is identified, partner testing should be offered for genetic counseling regarding risk to offspring.

Athletes

The test is used for screening by organizations like the NCAA and US military 1. Positive results require confirmation before any activity restrictions.

Quality Control Considerations

For reliable results 2, 4:

• Follow manufacturer's instructions precisely
• Use proper centrifugation technique
• Ensure adequate sample quality (no hemolysis, lipemia, or icterus when possible)
• Confirm all positive results with electrophoresis or HPLC
• Consider that samples with HbF >15-20% or other variants may require DNA sequencing for definitive diagnosis

The solubility test remains an excellent screening tool when used appropriately, but it is never sufficient as a standalone diagnostic test 1, 2.